TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
PLYX

Polaryx Therapeutics, Inc.

Healthcare · Biotechnology

1.90$ -3.6% vs. previous close Closing price · As of: Nov 12, 2026

Statements

Balance Sheet

Polaryx Therapeutics, Inc. (PLYX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 5.4 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PLYX
Line item 2023 2024 2025
2.3 5.0 5.4
2.3 5.0 5.2
0.0 4.6 5.1
0.0 4.6 5.1
1.0 0.3 0.9
1.0 0.3 0.6
0.1 – –
0.5 0.1 0.5
1.3 4.7 4.6
-60 -91 -100
189 189 47

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?